+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Uveitis"

From
United Arab Emirates Retinal Biologics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Arab Emirates Retinal Biologics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • January 2024
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
US Uveitis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Uveitis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
Equine Ophthalmology. Edition No. 4 - Product Thumbnail Image

Equine Ophthalmology. Edition No. 4

  • Book
  • July 2022
  • 896 Pages
Rapid Ophthalmology. Edition No. 1 - Product Thumbnail Image

Rapid Ophthalmology. Edition No. 1

  • Book
  • September 2013
  • 152 Pages
Ophthalmology. Lecture Notes. Edition No. 13 - Product Thumbnail Image

Ophthalmology. Lecture Notes. Edition No. 13

  • Book
  • April 2024
  • 272 Pages
Loading Indicator

Uveitis is a medical condition that affects the uvea, the middle layer of the eye. It is characterized by inflammation of the uvea, which can lead to vision loss and other complications. In the context of optical, uveitis is a major cause of vision loss and can be treated with a variety of treatments, including topical and systemic medications, laser treatments, and surgery. Uveitis is a growing market in the optical industry, as it is a common cause of vision loss and can be treated with a variety of treatments. Companies in the uveitis market include Bausch + Lomb, Novartis, Allergan, and Santen Pharmaceuticals. These companies offer a range of treatments for uveitis, including topical and systemic medications, laser treatments, and surgery. Show Less Read more